Thematic, Nifty MidSmall Healthcare
A healthcare momentum basket: 10 stocks from Nifty MidSmall Healthcare, rotated weekly. The healthcare thematic satellite.
Written for growth-oriented investors comfortable with double-digit drawdowns.
High risk band
01At a glance
₹100 in the model in May 2021 became ₹210 by Jul 2026; the Nifty 50 TRI line reached ₹162. Model, back tested. As of 27 Apr 2026. After charges, log scale. Not a promise of future returns.
02Three steps
Line Healthcare Basket up against the other 17 strategies, and against funds, PMS and AIF.
Compare strategiesEvery year, month, fall, holding and rebalance is in the factsheet below.
Open the factsheetLink your broker and approve each rebalance. Stocks stay in your own demat; RupeeCase never holds your money.
Invest in Healthcare Basket03Factsheet
Every figure behind the four numbers, in seven parts. Return figures are model, back tested and after charges; each block names its date.
Model, back tested, after charges, 2021 to May 2026. Not a promise of future returns.
Model, back tested: the published monthly model returns after charges, May 2021 to May 2026 (61 months). A back test, not a promise of future returns.
Move across the record to read how far the model sat below its last peak, and how long it took to climb back.
Model, back tested. As of 27 Apr 2026. The scrub reads month end model values from May 2021 to Jul 2026, so its falls read shallower than the daily figures on the buttons; days are counted between month ends. Drawdowns of similar size can happen again. High risk band.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | Janno data | Febno data | Marno data | Aprno data | May2.8 | Jun3.0 | Jul3.2 | Aug−0.8 | Sep−1.7 | Oct−8.3 | Nov3.6 | Dec3.2 | Year+4.4% |
| 2022 | Jan−7.5 | Feb−6.3 | Mar2.7 | Apr−2.6 | May−10.1 | Jun−7.1 | Jul9.7 | Aug−1.8 | Sep−0.2 | Oct4.4 | Nov1.9 | Dec−2.9 | Year−19.6% |
| 2023 | Jan−6.5 | Feb0.2 | Mar3.9 | Apr7.9 | May5.5 | Jun9.8 | Jul7.0 | Aug2.2 | Sep3.4 | Oct−6.3 | Nov12.4 | Dec8.7 | Year+57.2% |
| 2024 | Jan4.7 | Feb5.4 | Mar−6.4 | Apr1.7 | May−5.7 | Jun12.1 | Jul7.4 | Aug12.8 | Sep−3.0 | Oct1.2 | Nov6.8 | Dec−0.7 | Year+40.0% |
| 2025 | Jan−8.6 | Feb−11.0 | Mar11.5 | Apr0.8 | May1.0 | Jun10.5 | Jul5.1 | Aug−4.9 | Sep0.2 | Oct4.8 | Nov−5.1 | Dec−1.1 | Year+0.6% |
| 2026 | Jan−5.4 | Feb7.7 | Mar−2.6 | Apr8.9 | May7.4 | Junno data | Julno data | Augno data | Sepno data | Octno data | Novno data | Decno data | Year to date+16.2% |
Model, back tested, after charges. Each cell is one calendar month, in percent. Not a promise of future returns.
Return over each 12 month window.
CAGR over each 36 month window.
Model, back tested, from the month end model values, May 2021 to Jul 2026. Not a promise of future returns.
Model, back tested, daily record over rolling 5 years: from the peak to the low, and the days until the record was back at that peak.
Live quantities, prices and book values are in the app
Weights on the rebalance day, 11 May 2026; they drift with prices until the next rebalance. Model portfolio, not a recommendation to buy or sell any stock.
2 sectors in the equity sleeve; the largest mapped sector is Pharma & Healthcare at 60.2%, and 39.8% of the sleeve is not yet in the sector map. 100% pharma and healthcare by design. Mid and small cap specialty pharma, hospitals, life sciences, and CDMOs. No single-name allocation above ~11%. Sector map curated against NSE listings.
| Sector | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Now |
|---|---|---|---|---|---|---|---|
| Pharma & Healthcare | 26 | 26 | 28 | 35 | 27 | 59 | 55 |
| Other, not yet mapped | 74 | 74 | 72 | 65 | 73 | 41 | 45 |
261 published rebalances, 2 sectors touched, 2 held on the latest list (8 May 2026). Each cell is the average weight that year, equal weighted at the stock level; darker is a higher weight.
Rebalances run on a fixed calendar; you approve each one before your broker places the orders.
Against the list of 1 May 2026: 1 in, 3 out, 10 held, 11 on the list.
Model portfolio, back tested rebalance record. Entered plus held is that date's list size, which can differ from the 10 stock target. Tickers are not recommendations.
| Date | On the list | In | Out |
|---|---|---|---|
| 8 May 2026 | 11 | +1 | −3 |
| 1 May 2026 | 13 | +3 | −1 |
| 24 Apr 2026 | 11 | +1 | 0 |
| 17 Apr 2026 | 10 | 0 | −1 |
| 10 Apr 2026 | 11 | +1 | −1 |
| 3 Apr 2026 | 11 | +1 | −1 |
| 27 Mar 2026 | 11 | +1 | 0 |
| 20 Mar 2026 | 10 | 0 | −2 |
| 13 Mar 2026 | 12 | +2 | −1 |
| 6 Mar 2026 | 11 | +1 | −3 |
| 27 Feb 2026 | 13 | +3 | −2 |
| 20 Feb 2026 | 12 | +2 | 0 |
Every rebalance with its namesRebalance history, CSV
Names on the list, names in and names out at each date; the history page and the CSV have every name.
11 such shifts in 261 rebalances; the latest six. Equity sleeve, equal weighted at the stock level.
| Metric | Healthcare Basket | Nifty 50 |
|---|---|---|
| Sharpe ratio | 0.89 | 0.73 |
| Sortino ratio | 0.89 | 0.70 |
| Calmar ratio | 0.50 | 0.58 |
| Volatility, a year | 19.44% | 14.04% |
| Max drawdown | −33.29% | −16.92% |
| Best week | +8.24% | +6.36% |
| Worst week | −9.01% | −6.33% |
| Weeks up | 57.47% | 57.47% |
| Average up week | +2.10% | +1.49% |
| Average down week | −2.05% | −1.57% |
Model, back tested, after charges. Weekly figures over the rolling 5 years window to 27 Apr 2026; the Nifty 50 over the same window. Not a promise of future returns.
High on a scale from Low to Very High
CAGR, Sharpe and max drawdown on the cards: Model, back tested. As of 27 Apr 2026. Take the risk profile to see which bands sit within yours.
Start from the Nifty MidSmall Healthcare, filtered to stocks priced under ₹5,000.
Score every stock in the universe by a momentum composite: price trend over several look backs, risk adjusted. The top names by score become the candidate list.
Hold the top 10 names by score, equal weighted so no single name dominates.
Every week the model runs again end to end. Names that fall out of the top 10 are sold; new entrants are bought. The full list is published at every rebalance.
The second thematic satellite card on the lineup, alongside Energy Basket. The index screens the Nifty MidSmall Healthcare universe for the top 10 momentum-ranked stocks priced under 5000, holds them equal-weighted at roughly 10% each, and rotates every week.
It rotates weekly like Energy Basket, but the universe is a different sector: mid and small cap pharma, hospitals, and life sciences. Healthcare runs on its own cycle, capex, approvals, and pricing rather than commodities, which is exactly why it earns a satellite slot next to an energy tilt.
Ten names from one sector means the card moves as a bloc when sector-wide news lands. The momentum screen decides which ten. The sector decides the weather.
This is NOT a core holding. Single-sector concentration risk is real, pharma stocks move together when USFDA decisions, domestic price caps, or hospital reimbursement rules shift. Investors without that view should put the same capital into Allcap or Midcap Smallcap instead.
A description of the strategy, not a recommendation. Decide your own allocation, or ask a SEBI registered investment adviser.
Machine learning is used in research to search and optimise the model behind each strategy: which signals rank the universe, how many names to hold and how often to rebalance, tested out of sample. The rule that ships is then frozen and published, so the live strategy is a fixed, readable algorithm, not a black box that changes on its own.
Free modules from the RupeeCase Learn library. No sign up.
0.2%of traded value, charged only when a rebalance trades
Higher turnover or more capital raises the fee in proportion.
Model, back tested, cumulative over the rolling 5 years window to 27 Apr 2026. Net is gross minus estimated costs, as on the current factsheet. Not a promise of future returns.
RupeeCase is a technology platform, not a fund, a PMS or a SEBI registered investment adviser. Model, back tested. As of 27 Apr 2026. Model figures are after estimated charges and are not actual client returns. Past performance does not guarantee future returns; capital can be lost.
04Questions
10 stocks from Nifty MidSmall Healthcare, rotated weekly. The defensive thematic satellite. It selects the top 10 momentum names from Nifty MidSmall Healthcare and rebalances every week.
About ₹36,000, enough to hold one share of every name in the current book at recent prices. The figure moves with the prices of the holdings.
Healthcare Basket shows a model CAGR of 15.19% against 9.80% for the Nifty 50 TRI CAGR line (Jan 2021 to Jul 2026), with a Sharpe ratio of 0.89. Model, back tested. As of 27 Apr 2026. Past performance does not guarantee future returns.
33.29% peak to trough in the model record. The deepest period ran 735 days, from 23 Jul 2021 to 28 Jul 2023. Model, back tested. As of 27 Apr 2026. Drawdowns of similar size can happen again, so size the position for it.
0.2% of traded value per rebalance. No subscription, no AUM fee, no performance fee. On the minimum capital of ₹36,000, the platform fee works out to about ₹1,120 a year (3.12% of capital). Assumptions: 52 rebalances a year (every week), 30% of the book traded at each rebalance, 0.2% of traded value. Higher turnover or more capital raises the fee in proportion. Broker side charges (brokerage, STT, exchange charges, GST) are separate.
Yes. No lock-in. Holdings sit in your own broker demat account and you can sell any name on any market day. Switching strategies or pausing the rebalance is a one-click action on the platform.
05Same family
CAGR and Max DD on the cards: Model, back tested. As of 27 Apr 2026.
Explore next
Ready when you are
15.19% CAGR, model, back tested. About ₹36K to start. Every week, you approve each one.
0.2% of traded value per rebalance. No AUM fee, no lock in. Line behind: the Healthcare Basket model record, after charges, as of 27 Apr 2026. Not a promise of future returns.
